The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people.
The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people. ...
More Stories
Ola#39;s Bhavish Aggarwal looks to disrupt India#39;s EV market by mass producing vehicles
Warburg Pincus arm to invest Rs 800 crore for 0.49% stake in Adani Ports
Consumption driving India’s economic revival: ASSOCHAM